0.54%
-12.47%
-10.36%
-24.08%
-21.27%
-11.43%
-6.30%
AI Spotlight on TSTL
Company Description
Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally.The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other.It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand; contamination control products, which include cleanroom, laboratory, pharmaceutical, cosmetic, and toiletry disinfectants under the Crystel brand; and airborne and veterinary device disinfectants under the Anistel brand.
The company was founded in 1993 and is headquartered in Snailwell, the United Kingdom.
Market Data
| Last Price | 372 |
| Change Percentage | 0.54% |
| Open | 366.5 |
| Previous Close | 370 |
| Market Cap ( Millions) | 177 |
| Volume | 12603 |
| Year High | 510 |
| Year Low | 346 |
| M A 50 | 405.95 |
| M A 200 | 430.69 |
Financial Ratios
| FCF Yield | 5.60% |
| Dividend Yield | 3.63% |
| ROE | 20.43% |
| Debt / Equity | 18.09% |
| Net Debt / EBIDTA | -2.94% |
| Price To Book | 5.44 |
| Price Earnings Ratio | 27.19 |
| Price To FCF | 17.86 |
| Price To sales | 4.23 |
| EV / EBITDA | 18.96 |
News
- Jan -22 - January 2025's Rising Stars: UK Penny Stocks To Watch
- Dec -24 - 3 UK Penny Stocks With Market Caps Over £70M To Watch
- Dec -03 - 3 UK Stocks That May Be Undervalued By Up To 20.8%
- Nov -25 - Discover Promising Penny Stocks On The UK Exchange This November 2024
- Nov -23 - Tristel (LON:TSTL) Is Increasing Its Dividend To £0.0828
- Nov -21 - Tristel plc (LON:TSTL) is a favorite amongst institutional investors who own 80%
- Nov -04 - 3 UK Stocks That May Be Priced Below Intrinsic Value In November 2024
- Oct -22 - UK Penny Stocks To Watch In October 2024
- Oct -22 - Tristel plc's (LON:TSTL) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
- Sep -20 - Investors in Tristel (LON:TSTL) have seen respectable returns of 53% over the past five years
- Aug -26 - Calculating The Intrinsic Value Of Tristel plc (LON:TSTL)
- Apr -29 - Tristel plc's (LON:TSTL) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
- Apr -26 - Stocks to watch this week: Amazon, Apple, Anglo American and Novo Nordisk
- Mar -18 - Tristel plc's (LON:TSTL) Intrinsic Value Is Potentially 21% Below Its Share Price
- Dec -29 - Tristel plc (LON:TSTL) is favoured by institutional owners who hold 85% of the company
- Dec -03 - Should You Be Adding Compagnie Financière Tradition (VTX:CFT) To Your Watchlist Today?
- Nov -21 - Can Mixed Fundamentals Have A Negative Impact on Tristel plc (LON:TSTL) Current Share Price Momentum?
- Nov -17 - Britain’s smaller stocks will ultimately recover and our IHT portfolio is poised to benefit
- Nov -03 - Investors Will Want Emmi's (VTX:EMMN) Growth In ROCE To Persist
- Nov -03 - As Tecan Group (VTX:TECN) lifts 4.9% this past week, investors may now be noticing the company's three-year earnings growth
Business Breakdown
Expected Mid-Term Growth
Segment n°1 -> Hospital Medical Device Decontamination
Expected Growth : 12 %
What the company do ?
Tristel plc's Hospital Medical Device Decontamination is a process that uses chlorine dioxide to disinfect and sterilize medical instruments, reducing the risk of hospital-acquired infections.
Why we expect these perspectives ?
Tristel plc's Hospital Medical Device Decontamination segment growth of 12% is driven by increasing demand for infection prevention, rising regulatory requirements, and growing adoption of automated decontamination systems. Additionally, the company's expanding product portfolio, strategic partnerships, and geographic expansion into new markets contribute to its growth momentum.
Segment n°2 -> Hospital Environmental Surface Disinfection
Expected Growth : 10 %
What the company do ?
Hospital Environmental Surface Disinfection from Tristel plc is a system that effectively kills 99.99% of bacteria, viruses, and fungi on surfaces, reducing hospital-acquired infections.
Why we expect these perspectives ?
Tristel plc's Hospital Environmental Surface Disinfection segment growth is driven by increasing concerns over hospital-acquired infections, rising demand for effective infection prevention, and growing adoption of eco-friendly disinfectants. Additionally, the COVID-19 pandemic has accelerated the need for enhanced surface disinfection protocols, further fueling growth.
Segment n°3 -> Other
Expected Growth : 16 %
What the company do ?
Tristel plc's 'Other' segment includes sales of hospital disinfectants and other infection prevention products to non-healthcare markets.
Why we expect these perspectives ?
Tristel plc's 16% growth is driven by increasing demand for infection prevention products, expansion into new geographies, and strategic partnerships. The company's focus on innovation, particularly in its proprietary chlorine dioxide technology, has also contributed to its growth. Additionally, the rising awareness of healthcare-associated infections and the need for effective disinfection solutions have fueled the demand for Tristel's products.
Tristel Plc Products
| Product Range | What is it ? |
|---|---|
| Tristel Wipes | A range of disinfectant wipes used for surface disinfection and cleaning in healthcare settings. |
| Tristel Foam | A foam-based disinfectant used for hand hygiene and surface disinfection. |
| Tristel Duo | A combination of a disinfectant wipe and a cleaning wipe used for surface cleaning and disinfection. |
| Tristel Corona | A range of disinfectant products used for surface disinfection and cleaning in healthcare settings. |
| Tristel Sporicidal Wipes | A range of sporicidal wipes used for surface disinfection and cleaning in healthcare settings. |
Tristel plc's Porter Forces
Threat Of Substitutes
Tristel plc's products are moderately susceptible to substitutes, as customers have some alternatives, but they are not easily accessible.
Bargaining Power Of Customers
Tristel plc's customers have limited bargaining power due to the company's strong brand reputation and limited availability of alternatives.
Bargaining Power Of Suppliers
Tristel plc's suppliers have moderate bargaining power, as the company relies on a few key suppliers, but has some flexibility to switch to alternative suppliers.
Threat Of New Entrants
The threat of new entrants is high in Tristel plc's industry, as the barriers to entry are relatively low, and new companies can easily enter the market.
Intensity Of Rivalry
The intensity of rivalry in Tristel plc's industry is high, as there are many competitors, and the market is highly competitive.
Capital Structure
| Value | |
|---|---|
| Debt Weight | 14.45% |
| Debt Cost | 3.96% |
| Equity Weight | 85.55% |
| Equity Cost | 5.25% |
| WACC | 5.06% |
| Leverage | 16.89% |
Tristel plc : Quality Control
Tristel plc passed 9 out of 9 key points:
Historical Valuation
Price/Earnings Ratio
Margin Valuation
Peers Valuation
Competitors
| Company | Rational |
|---|---|
| TDVOX.ST | Tobii Dynavox AB (Publ) develops and sells assistive technology products for communication in Sweden and internationally. The company provides technology and solutions for augmentative and alternative communication for people with … |
| VBSN.SW | IVF Hartmann Holding AG provides medical consumer goods in Switzerland and internationally. The company offers surgical disposable instruments, blankets, clothing and gloves, disinfection and hygiene products, wound management and hydrotherapy … |
| SKAN.SW | SKAN Group AG provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Asia, Europe, the Americas, and internationally. It operates in two segments: Equipment and Solutions … |
| BIOT.ST | Biotage AB (publ) provides separation technologies in the areas of organic and analytical chemistry, biomolecules, and industrial scale up applications. The company offers organic and peptide synthesis solutions; flash chromotherapy, … |
| SYNSAM.ST | Synsam AB (publ), through its subsidiaries, operates as an optical retailer in the Nordic Region. The company offers glasses, sunglasses, sports glasses, and contact lenses, as well as glasses and … |
Peers Metrics
DCF BETA
Expected Cash-Flows
Scoring Insights
Peers Group Analysis
🥇
IVF Hartmann Holding
A-Score
1-Year Total Return ->
🥈
Synsam
A-Score
1-Year Total Return ->
🥉
SKAN
A-Score
1-Year Total Return ->
4
Biotage
A-Score
1-Year Total Return ->
5
Tristel
A-Score
1-Year Total Return ->
6
